Drug and clinical candidate information for f2r (ChEMBL ID: CHEMBL3974):

Molecule: VORAPAXAR SULFATE
ChEMBL ID: CHEMBL2107386
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2014

Molecule: ATOPAXAR
ChEMBL ID: CHEMBL2103856
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PZ-128
ChEMBL ID: CHEMBL4297323
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein
